Vaxcyte, Inc.

PCVX · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $8.2B · 507 employees
112
SEC Filings
$66.36
Close 2026-11-10
507
Employees

Business Summary

Vaxcyte, Inc. is a clinical-stage vaccine innovation company developing high-fidelity vaccines against bacterial diseases using its XpressCF cell-free protein synthesis platform. Its pipeline includes VAX-31 (31-valent pneumococcal conjugate vaccine for adults and children), VAX-24 (24-valent PCV for infants), VAX-XL (next-generation broad-spectrum PCV), VAX-A1 (Group A Streptococcus conjugate vaccine), and VAX-GI (Shigella vaccine). VAX-31 has FDA breakthrough therapy designation for prevention of IPD and pneumonia in adults.

Latest Stock Quote

PCVX 2026-11-10 $66.36 O:$67 H:$68.18 L:$65.85 Vol:1.3M VWAP:$66.6503
origin leaf: null

Next Earnings

expected 2027-01-04

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-242025-12-310001649094-26-000007EDGAR111K words
2025-02-252024-12-310001649094-25-000028EDGAR105K words
2024-02-272023-12-310000950170-24-021145EDGAR118K words
2023-02-272022-12-310000950170-23-004654EDGAR109K words
2022-02-282021-12-310000950170-22-002281EDGAR101K words
2021-03-292020-12-310001564590-21-016110EDGAR96K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-11-042026-09-300001649094-26-000054EDGAR69K words
2026-08-052026-06-300001649094-26-000043EDGAR64K words
2025-11-042025-09-300001649094-25-000114EDGAR65K words
2025-08-062025-06-300001649094-25-000098EDGAR65K words
2025-05-072025-03-310001649094-25-000074EDGAR64K words
2024-11-052024-09-300001649094-24-000097EDGAR71K words
2024-08-062024-06-300001649094-24-000052EDGAR70K words
2024-05-082024-03-310001628280-24-021677EDGAR68K words
2023-11-062023-09-300000950170-23-059395EDGAR75K words
2023-08-082023-06-300000950170-23-039817EDGAR73K words
2023-05-082023-03-310000950170-23-018835EDGAR70K words
2022-11-072022-09-300000950170-22-022597EDGAR70K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-11-040001649094-26-000051EDGAR3K words
2026-10-090001193125-26-419174EDGAR48K words
2026-10-050001193125-26-413168EDGAR3K words
2026-09-030001649094-26-000045EDGAR2K words
2026-08-050001649094-26-000041EDGAR3K words
2026-07-150001649094-26-000030EDGAR1K words
2026-02-240001193125-26-067546EDGAR23K words
2026-02-240001649094-26-000005EDGAR4K words
2026-02-020001193125-26-033578EDGAR22K words
2025-12-190001649094-25-000116EDGAR1K words

112 total filings indexed. 84 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

pneumococcal-vaccine-market adult-vaccination pediatric-vaccination group-a-streptococcus-vaccine-market shigella/dysentery-vaccine-market global-vaccine-market opsonophagocytic-activity-(opa)-immunogenicity-criteria igg-seroconversion-rate-threshold-(0.35-mcg/ml) cdc-active-bacterial-core-(abc)-surveillance-data

Company Identity

CIK0001649094
TickerPCVX
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.vaxcyte.com
Listed2020-06-12

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: bedc78b8f6bc242f52ee57f735423f3644bb86e0333172441fad5149383e7f0e
parent: d6cf891107c4ad9d485089fb2e3a64a0582833f6ab15208695be912194bdaf25
content hash: 0067e5307c35a370fe593a82a4684ffccc3e1faa84d6715734f5e54688fd3d14
signed: 2026-11-16T19:04:06.862Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up PCVX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on PCVX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/PCVX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.